Understanding non-tuberculous mycobacterial infections in Alsace
State of Play of Non-tuberculous Mycobacteria in Alsace: a Retrospective Study
This study is looking at how common non-tuberculous mycobacterial infections are in the Alsace region of France and how they affect people's health over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06185166 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the incidence of non-tuberculous mycobacterial infections in the Alsace region of France. It will evaluate how many of these infections lead to illness and track changes over time. By analyzing biological samples that test positive for non-tuberculous mycobacteria, the study seeks to establish a clearer understanding of the disease's impact and prevalence in the area. The findings will help inform the development of a coordinated care pathway for affected patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have a culture-positive biological sample for non-tuberculous mycobacteria and reside in Alsace.
Not a fit: Patients who are not domiciled in Alsace or have infections caused by mycobacteria from the Tuberculosis complex will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of non-tuberculous mycobacterial infections in the Alsace region.
How similar studies have performed: While there may be limited studies on non-tuberculous mycobacteria, this specific focus on the Alsace region is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult subject (≥ 18 years old) * in whom a biological sample is culture positive for a non-tuberculous mycobacterium * born in France and domiciled in Alsace (i.e. whose home postal code begins with 67 or 68) * not opposing the reuse of its data for scientific research purposes Exclusion Criteria: * Subject having expressed opposition to participating in the study * not domiciled in Alsace * Born abroad * Isolation of a mycobacterium from the Tuberculosis complex and Mycobacterium gordonae
Where this trial is running
Strasbourg
- Service de Pneumologie - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Loïc KASSEGNE, MD
- Email: loic.kassegne@chru-strasbourg.fr
- Phone: 33 3 69 55 01 88
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.